课题基金 / 基金详情

BIOLOGICAL CONSEQUENCES OF PROTEIN OXIDATION

BIOLOGICAL CONSEQUENCES OF PROTEIN OXIDATION
蛋白质氧化的生物学后果
批准号:
6161323
负责人:
E B SHACTER
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

E B SHACTER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Reactive oxygen compounds such as O2- and H2O2 are generated under numerous circumstances in vivo and in vitro. In the presence of transition metals (e.g., iron, copper), these compounds induce covalent modifications in cellular and purified macromolecules including proteins, DNA, and lipids. Oxidants are thought to contribute to the etiology of a wide array of pathologic conditions including ischemia-reperfusion injury, atherosclerosis, chronic inflammation, and cancer. The focus of our work is to elucidate the consequences of exposure of biological substrates to oxidative stress. In these studies, we examined mechanisms of induction of cytotoxicity by H2O2 with emphasis on understanding the ramifications for tumor cell biology. Most pre-clinical safety studies use animals for the establishment of expected toxicities. These tests are costly monetarily and in terms of animal life. We are setting up a battery of in vitro pre-clinical assays to assess cell killing. The field of cytotoxicity has advanced so rapidly that methods that were accepted 10 years ago are no longer adequate. For example, we now know that cells dying by apoptosis exclude vital dyes and that agents that kill by this mechanism can be mistakenly diagnosed as non-toxic. The development of valid in vitro models for cytoxicity will enable us to promote better pre-clinical testing and will enhance our ability to regulate anti-cancer drugs. Our work shows that the mechanism through which a drug kills tumor cells will impact its efficacy and side effects. Cytotoxicity is also relevant for regulating thrombolytic agents since thrombolysis can lead to reperfusion injury, thought to be caused by oxygen radicals. Future treatments for infarction may involve combination therapies that include anti-oxidants. Our work gives the agency the expertise required to regulate novel therapeutic approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF INTERLEUKIN-6 (IL-6)
  • 批准号:
    2569002
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    E B SHACTER
  • 依托单位:
    --
BIOLOGICAL CONSEQUENCES OF PROTEIN OXIDATION
  • 批准号:
    6101263
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    E B SHACTER
  • 依托单位:
    --
REGULATION OF INTERLEUKIN-6 (IL-6)
  • 批准号:
    5200786
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    E B SHACTER
  • 依托单位:
    --
REGULATION OF INTERLEUKIN-6 (IL-6)
  • 批准号:
    6101262
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    E B SHACTER
  • 依托单位:
    --